arrow
D

Donald R. Lannin

Yale University
H指数:39
被引数:6,869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer (vol 7, 9, 2021)
2022-02-031
OAAI
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
2021-02-0845
OAAI
The impact of communication style on patient satisfaction
2019-04-2525
PREAI